Browse
Submit Data
Databases
API
Help

Dataset Information

15 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy.

ABSTRACT: A Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20129-9.

SUBMITTER: Galstyan A

PROVIDER: S-EPMC7692458 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy.

Galstyan Anna A Markman Janet L JL Shatalova Ekaterina S ES Chiechi Antonella A Korman Alan J AJ Patil Rameshwar R Klymyshyn Dmytro D Tourtellotte Warren G WG Israel Liron L LL Braubach Oliver O Ljubimov Vladimir A VA Mashouf Leila A LA Ramesh Arshia A Grodzinski Zachary B ZB Penichet Manuel L ML Black Keith L KL Holler Eggehard E Sun Tao T Ding Hui H Ljubimov Alexander V AV Ljubimova Julia Y JY

Nature communications 20201126 1

A Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20129-9. ...[more]

PMID: 33243989

Similar Datasets

Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy.

Project description:Brain glioma treatment with checkpoint inhibitor antibodies to cytotoxic T-lymphocyte-associated antigen 4 (a-CTLA-4) and programmed cell death-1 (a-PD-1) was largely unsuccessful due to their inability to cross blood-brain barrier (BBB). Here we describe targeted nanoscale immunoconjugates (NICs) on natural biopolymer scaffold, poly(?-L-malic acid), with covalently attached a-CTLA-4 or a-PD-1 for systemic delivery across the BBB and activation of local brain anti-tumor immune response. NIC treatment of mice bearing intracranial GL261 glioblastoma (GBM) results in an increase of CD8+ T cells, NK cells and macrophages with a decrease of regulatory T cells (Tregs) in the brain tumor area. Survival of GBM-bearing mice treated with NIC combination is significantly longer compared to animals treated with single checkpoint inhibitor-bearing NICs or free a-CTLA-4 and a-PD-1. Our study demonstrates trans-BBB delivery of tumor-targeted polymer-conjugated checkpoint inhibitors as an effective GBM treatment via activation of both systemic and local privileged brain tumor immune response.

| S-EPMC6713723 | biostudies-literature

Author Correction: The role of oxygen-permeable ionomer for polymer electrolyte fuel cells

Project description: Not available

| S-EPMC10474015 | biostudies-literature

Author Correction: Dissociation of structural and functional connectomic coherence in glioma patients.

Project description: Not available

| S-EPMC10070241 | biostudies-literature

Author Correction: Novel nano composites from Citrus limon and Citrullus colocynthis agricultural wastes for biomedical applications.

Project description: Not available

| S-EPMC11339262 | biostudies-literature

Author Correction: A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma.

Project description: Not available

| S-EPMC10079822 | biostudies-literature

Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging.

Project description:The blood-brain barrier (BBB) remains a formidable obstacle in medicine, preventing efficient penetration of chemotherapeutic and diagnostic agents to malignant gliomas. Here, a transactivator of transcription (TAT) peptide-modified gold nanoparticle platform (TAT-Au NP) with a 5 nm core size is demonstrated to be capable of crossing the BBB efficiently and delivering cargoes such as the anticancer drug doxorubicin (Dox) and Gd(3+) contrast agents to brain tumor tissues. Treatment of mice bearing intracranial glioma xenografts with pH-sensitive Dox-conjugated TAT-Au NPs via a single intravenous administration leads to significant survival benefit when compared to the free Dox. Furthermore, it is demonstrated that TAT-Au NPs are capable of delivering Gd(3+) chelates for enhanced brain tumor imaging with a prolonged retention time of Gd(3+) when compared to the free Gd(3+) chelates. Collectively, these results show promising applications of the TAT-Au NPs for enhanced malignant brain tumor therapy and non-invasive imaging.

| S-EPMC4268041 | biostudies-literature

Author Correction: HIV-1 Transmissions Among Recently Infected Individuals in Southwest China are Predominantly Derived from Circulating Local Strains.

Project description:A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

| S-EPMC6255844 | biostudies-other

Author Correction: Psychological measures aren’t toothbrushes

Project description: Not available

| S-EPMC11332099 | biostudies-literature

Author Correction: Diffraction-limited ultrabroadband terahertz spectroscopy.

Project description:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

| S-EPMC7170850 | biostudies-literature

Erratum: Author Correction: System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheep.

Project description:[This corrects the article DOI: 10.1038/s41541-018-0078-0.].

| S-EPMC6381089 | biostudies-literature